๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment

โœ Scribed by Oglodek, E.; Szota, A.; Araszkiewicz, A.

Book ID
124158092
Publisher
Informa plc
Year
2013
Tongue
English
Weight
64 KB
Volume
47
Category
Article
ISSN
0004-8674

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A case of tetrabenazine-induced neurolep
A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment
โœ Giselle M. Petzinger; Susan B. Bressman ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 404 KB

We report the case of a patient with tardive dystonia and a history of psychiatric illness who showed signs of neuroleptic malignant syndrome (NMS) after chronic treatment with tetrabenazine. The first symptom was a mental status change 'consisting of confusion, disorganized thinking, paranoid delus

Rhabdomyolysis without neuroleptic malig
Rhabdomyolysis without neuroleptic malignant syndrome induced by additional treatment of risperidone
โœ Norio Yasui; Tsuyoshi Kondo; Koichi Otani; Sunao Kaneko ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 65 KB

This is the ยฎrst case report of rhabdomyolysis without neuroleptic malignant syndrome induced by additional treatment of risperidone. The manifestations of this side eect were symptoms of myalgia, muscle weakness and redcoloured urine with ยฎndings of markedly elevated levels of creatine kinase and m

Successful use of risperidone after neur
Successful use of risperidone after neuroleptic malignant syndrome (NMS): a 1-year follow-up
โœ Ashok N. Singh; David M. Hambidge ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 69 KB

Successful use of risperidone after neuroleptic malignant syndrome (NMS): a 1-year follow-up Neuroleptic malignant syndrome (NMS) is a rare and an acute life-threatening reaction that can occur in patients on neuroleptic medication. Few authors have addressed the issue of re-challenge in previous NM